Guo Qi, Zhu Hui, Xu Xi, Huang Tianyi, Pan Yulin, Gu Xiaosong, Cui Shusen, Xue Chengbin
Department of Hand and Foot Surgery, China-Japan Union Hospital of Jilin University, Key Laboratory of Peripheral Nerve Injury and Regeneration of Jilin Province, The Third Bethune Hospital of Jilin University, Changchun, JL, 130033, PR China.
Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-Innovation Center of Neuroregeneration, NMPA Key Laboratory for Research and Evaluation of Tissue Engineering Technology Products, Nantong University, Nantong, JS, 226001, PR China.
Mater Today Bio. 2024 Aug 9;28:101196. doi: 10.1016/j.mtbio.2024.101196. eCollection 2024 Oct.
Peripheral nerve injury is a major challenge in clinical treatment due to the limited intrinsic capacity for nerve regeneration. Tissue engineering approaches offer promising solutions by providing biomimetic scaffolds and cell sources to promote nerve regeneration. In the present work, we investigated the potential role of skin-derived progenitors (SKPs), which are induced into neurons and Schwann cells (SCs), and their extracellular matrix in tissue-engineered nerve grafts (TENGs) to enhance peripheral neuroregeneration. SKPs were induced to differentiate into neurons and SCs and incorporated into nerve grafts composed of a biocompatible scaffold including chitosan neural conduit and silk fibroin filaments. experiments using a rat model of peripheral nerve injury showed that TENGs significantly enhanced nerve regeneration compared to the scaffold control group, catching up with the autograft group. Histological analysis showed improved axonal regrowth, myelination and functional recovery in animals treated with these TENGs. In addition, immunohistochemical staining confirmed the presence of induced neurons and SCs within the regenerated nerve tissue. Our results suggest that SKP-induced neurons and SCs in tissue-engineered nerve grafts have great potential for promoting peripheral nerve regeneration and represent a promising approach for clinical translation in the treatment of peripheral nerve injury. Further optimization and characterization of these engineered constructs is warranted to improve their clinical applicability and efficacy.
由于神经再生的内在能力有限,周围神经损伤是临床治疗中的一项重大挑战。组织工程方法通过提供仿生支架和细胞来源来促进神经再生,从而提供了有前景的解决方案。在本研究中,我们研究了皮肤来源的祖细胞(SKP)及其细胞外基质在组织工程神经移植物(TENG)中的潜在作用,SKP可诱导分化为神经元和雪旺细胞(SC),以增强周围神经再生。将SKP诱导分化为神经元和SC,并将其整合到由生物相容性支架(包括壳聚糖神经导管和丝素蛋白丝)组成的神经移植物中。使用大鼠周围神经损伤模型进行的实验表明,与支架对照组相比,TENG显著增强了神经再生,接近自体移植组。组织学分析显示,用这些TENG治疗的动物轴突再生、髓鞘形成和功能恢复均有所改善。此外,免疫组织化学染色证实再生神经组织中存在诱导的神经元和SC。我们的结果表明,组织工程神经移植物中SKP诱导的神经元和SC在促进周围神经再生方面具有巨大潜力,是周围神经损伤临床治疗中一种有前景的方法。有必要对这些工程构建体进行进一步优化和表征,以提高其临床适用性和疗效。